Snapshot from Jul 29, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Technology / Puncture Robotic HAIRO Debut at WCHR 2026
Tech product launch

Puncture Robotic HAIRO Debut at WCHR 2026

Analysis based on 7 articles · First reported Jul 10, 2026 · Last updated Jul 10, 2026

Sentiment
20
Attention
1
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The launch of HAIRO may boost Puncture Robotic's valuation and attract further investment in AI-driven medical aesthetics. However, the event is niche and unlikely to significantly impact broader markets.

medical aesthetics surgical robotics
Event Summary

At the 14th World Congress for Hair Research (WCHR 2026) in Seoul, South Korea, Puncture Robotic debuted its HAIRO Hair Transplant Robot, China's first NMPA Class III-certified hair transplant robot. HAIRO integrates AI, computer vision, and robotic automation for hair restoration, featuring a 'Single-Hair Skipping' algorithm and sub-surface positioning accuracy of 0.1 mm. The system can process up to 2,400 follicles per hour with a follicular-unit damage rate below 7.5%. Puncture Robotic recently completed a multi-million-dollar Series B financing round led by a globally leading AI technology company and is pursuing FDA clearance and CE certification. A long-hair extraction version is in development.

Key Actions
90 Puncture Robotic completed Series B financing
80 Puncture Robotic showcased
60 Puncture Robotic preparing long-hair extraction version
Entities Involved
priv
Puncture Robotic
Puncture Robotic is the developer of HAIRO; the debut enhances its reputation and supports its expansion plans.
Importance 100.0 Sentiment 60.0
oth
HAIRO
HAIRO is the flagship product showcased; its technological features position it as a competitive hair transplant robot.
Importance 90.0 Sentiment 50.0
oth
World Congress for Hair Research
WCHR 2026 served as the venue for the product debut, providing a platform for industry exposure.
Importance 30.0 Sentiment 0.0
cnt
China
China is the home country of Puncture Robotic and the regulatory origin of HAIRO's NMPA certification.
Importance 30.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
FDA clearance is a target for international expansion; not yet obtained.
Importance 20.0 Sentiment 0.0
govactor
China — National Medical Products Administration
NMPA Class III certification is a regulatory milestone for HAIRO in China.
Importance 20.0 Sentiment 0.0
oth
CE marking
CE certification is a target for European market entry; not yet obtained.
Importance 20.0 Sentiment 0.0
cnt
South Korea
South Korea hosted WCHR 2026 in Seoul, where the debut took place.
Importance 20.0 Sentiment 0.0
per
Guanzhou Zhu
Dr. Guanzhou Zhu, founder of DCDC Hair Transplant Hospital, provided a positive testimonial for HAIRO.
Importance 10.0 Sentiment 0.0
priv
DCDC Hair Transplant Hospital
DCDC Hair Transplant Hospital is a potential customer or partner; mentioned in a testimonial.
Importance 10.0 Sentiment 0.0
Relationships
China related ↔ United States — Food and Drug Administration
China related ↔ China — National Medical Products Administration
China related ↔ South Korea
United States — Food and Drug Administration related ↔ China — National Medical Products Administration
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.